Association between perioperative NSAID use and post-cardiothoracic surgery atrial fibrillation, blood transfusions, and cardiovascular outcomes: A nested cohort study from the AF Suppression Trials (AFIST) I, II and III

Current Medical Research and Opinion

Volumn 24, Issue 4, 2008, Pages 1131-1136

  Ruffin Jr , Richard T ^c   Kluger, Jeffrey ^c   Baker, William L ^c   Wills, Stephanie M ^c   White, C Michael ^c   Coleman, Craig I ^a,b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b HARTFORD HOSPITAL   (United States)

^c NONE

Author keywords

Atrial fibrillation; Cardiac surgery; Nonsteroidal anti inflammatory drugs; NSAID

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROMORPHONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PARACETAMOL; STATIN;

AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD TRANSFUSION; CARDIOVASCULAR RISK; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; RANDOMIZED CONTROLLED TRIAL; STROKE; THORAX SURGERY;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATRIAL FIBRILLATION; BLOOD TRANSFUSION; CARDIOVASCULAR SURGICAL PROCEDURES; FEMALE; HUMANS; INCIDENCE; MALE; PERIOPERATIVE CARE; PROSPECTIVE STUDIES; RISK FACTORS; THORACIC SURGICAL PROCEDURES; TIME FACTORS; TREATMENT OUTCOME;

EID: 42549150339     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079908X280671     Document Type: Article

References (20)

1. Hall RI, Smith MS, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacologic considerations. Anesth Analg 1997;85:195-9
2. Baker WL, White CM. Post-cardiothoracic surgery atrial fibrillation: a review of preventive strategies. Ann Pharmacother 2007;41:587-98
3. Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation. J Am Coll Cardiol 2007;50:2021-8
4. Echahidi N, Pibarot P, O'Hara G, Mathieu P. Mechanisms prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 2008;51:793-801
5. Bruins P, Velthius HV, Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: post surgery activation involves c-reactive protein and is associated with postoperative arrhythmia. Circulation 1997;96:3542-8
6. Gaudino M, Andreotti F, Zamparelli R, et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation 2003;108(Suppl 1):II-195-9
7. Fontes ML, Mathew JP, Rinder TM, et al. Atrial fibrillation after cardiac surgery/cardiopulmonary bypass is associated with monocyte activation. Anesth Analg 2005;101:17-23
8. Cosgrove J, Foley JB, Kelly R, et al. Perioperative serum inflammatory response and the development of atrial fibrillation after coronary artery bypass surgery. Heart 2005;91:1475-6
9. Lamm G, Auer J, Weber T, et al. Postoperative white blood cell count predicts atrial fibrillation after cardiac surgery. J Cardiothorac Vasc Anesth 2006;20:51-6
10. Ishida K, Kimura F, Imamaki M, et al. Relation of inflammatory cytokines to atrial fibrillation after off-pump coronary artery bypass grafting. Eur J Cardiothorac Surg 2006;29:501-5
11. Baker WL, White CM, Kluger J, et al. Effect of perioperative corticosteroid use on the incidence of postcardiothoracic surgery atrial fibrillation and length of stay. Heart Rhythm 2007;4:461-8
12. Halonen J, Halonen P, Jarvinen O, et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery. A randomized controlled trial. JAMA 2007;297:1562-7
13. Cheruku KK, Ghani A, Ahmad F, et al. Efficacy of nonsteroidal anti-inflammatory medications for prevention of atrial fibrillation following coronary artery bypass graft surgery. Prev Cardiol 2004;7:13-18
14. Nussmeier NA, Whelton AA, Brown MT, et al. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 2005;352:1081-91
15. Giri S, White CM, Dunn A, et al. Oral amiodarone for prevention of atrial fibrillation after open heart surgery The Atrial Fibrillation Suppression Trial (AFIST): a randomized placebo-controlled trial. Lancet 2001;357-830-6
16. White CM, Caron MF, Kalus JS, et al. Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the Atrial Fibrillation Suppression Trial II (AFIST II). Circulation 2003;108(Suppl II):200-6
17. White CM, Sander S, Coleman CI, et al. Impact of epicardial anterior fat pad retention on post-cardiothoracic surgery atrial fibrillation incidence: The Atrial Fibrillation Suppression Trial III (AFIST III). J Am Coll Cardiol 2007;49:298-303
18. Coleman CI, Makanji S, Kluger J, White CM. Effect of angiotensin- converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation. Ann Pharmacother 2007;41:433-7
19. White CM, Coleman CI. Drug-induced cardiac diseases In: Dunsworth TS, Richardson MM (eds). Pharmacotherapy Self-Assessment Program, 6th edn, Book 1. Lanexa, MO: American College of Clinical Pharmacy, 2007:39-56
20. Ishida K, Kimura F, Imamaki M, et al. Relation of inflammatory cytokines to atrial fibrillation after off-pump coronary artery bypass grafting. Eur J Cardiothorac Surg 2006;29:501-5